NW Bio Congratulates Cognate BioServices On Its Management Buyout

February 20, 2018

Responsive image

BETHESDA, Md., Feb. 20, 2018 /PRNewswire/ — Northwest Biotherapeutics (OTCQB: NWBO) — (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, congratulated Cognate BioServices, the contract manufacturer of NWBio’s DCVax® products, on…

Category: Precious Metals